Previous studies have reported that miR-181b-5p functions in gliomas to suppress growth by targeting the IGF-1R oncogene [8] and modulates glioma cell sensitivity to temozolomide by targeting MEK1[9]. Here, MAP2K1 is linked to central nervous system cancer.